Advyzon Investment Management LLC Makes New Investment in Danaher Co. (NYSE:DHR)

Advyzon Investment Management LLC acquired a new stake in shares of Danaher Co. (NYSE:DHR) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 958 shares of the conglomerate’s stock, valued at approximately $220,000.

Other institutional investors have also recently made changes to their positions in the company. Heck Capital Advisors LLC purchased a new stake in Danaher in the fourth quarter valued at about $27,000. Decker Retirement Planning Inc. acquired a new position in shares of Danaher during the fourth quarter valued at about $31,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher in the 4th quarter valued at approximately $31,000. Strategic Financial Concepts LLC acquired a new stake in Danaher in the 4th quarter worth approximately $31,000. Finally, Pineridge Advisors LLC boosted its stake in Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 57 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

NYSE:DHR opened at $208.10 on Friday. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a market cap of $150.31 billion, a P/E ratio of 39.41, a P/E/G ratio of 2.61 and a beta of 0.83. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company’s 50-day moving average price is $227.21 and its 200-day moving average price is $247.52.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the business posted $2.09 EPS. On average, sell-side analysts forecast that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.32 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. Danaher’s dividend payout ratio is presently 20.45%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on DHR shares. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Robert W. Baird reduced their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $277.00 price target (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Finally, Jefferies Financial Group decreased their target price on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. Seven equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $278.00.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.